Zhang Zhenhe, Wang Rong, Xue Hang, Knoedler Samuel, Geng Yongtao, Liao Yuheng, Alfertshofer Michael, Panayi Adriana C, Ming Jie, Mi Bobin, Liu Guohui
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, China.
Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, 430022, China.
Biomater Res. 2023 Nov 28;27(1):123. doi: 10.1186/s40824-023-00458-8.
Musculoskeletal disorders (MSDs), which include a range of pathologies affecting bones, cartilage, muscles, tendons, and ligaments, account for a significant portion of the global burden of disease. While pharmaceutical and surgical interventions represent conventional approaches for treating MSDs, their efficacy is constrained and frequently accompanied by adverse reactions. Considering the rising incidence of MSDs, there is an urgent demand for effective treatment modalities to alter the current landscape. Phototherapy, as a controllable and non-invasive technique, has been shown to directly regulate bone, cartilage, and muscle regeneration by modulating cellular behavior. Moreover, phototherapy presents controlled ablation of tumor cells, bacteria, and aberrantly activated inflammatory cells, demonstrating therapeutic potential in conditions such as bone tumors, bone infection, and arthritis. By constructing light-responsive nanosystems, controlled drug delivery can be achieved to enable precise treatment of MSDs. Notably, various phototherapy nanoplatforms with integrated imaging capabilities have been utilized for early diagnosis, guided therapy, and prognostic assessment of MSDs, further improving the management of these disorders. This review provides a comprehensive overview of the strategies and recent advances in the application of phototherapy for the treatment of MSDs, discusses the challenges and prospects of phototherapy, and aims to promote further research and application of phototherapy techniques.
肌肉骨骼疾病(MSDs)包括一系列影响骨骼、软骨、肌肉、肌腱和韧带的病理状况,在全球疾病负担中占很大比例。虽然药物和手术干预是治疗MSDs的传统方法,但其疗效有限且常常伴有不良反应。鉴于MSDs的发病率不断上升,迫切需要有效的治疗方式来改变当前的局面。光疗法作为一种可控且非侵入性的技术,已被证明可通过调节细胞行为直接调控骨骼、软骨和肌肉的再生。此外,光疗法能对肿瘤细胞、细菌和异常激活的炎症细胞进行可控消融,在骨肿瘤、骨感染和关节炎等病症中显示出治疗潜力。通过构建光响应纳米系统,可以实现可控药物递送,从而对MSDs进行精准治疗。值得注意的是,各种具有集成成像能力的光疗法纳米平台已被用于MSDs的早期诊断、引导治疗和预后评估,进一步改善了对这些疾病的管理。本文综述全面概述了光疗法在治疗MSDs方面的策略和最新进展,讨论了光疗法面临的挑战和前景,旨在推动光疗法技术的进一步研究和应用。